ADARx Pharmaceuticals (ADRX) vs Innoviva (INVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ADARx Pharmaceuticals is the larger company by market cap ($1.88 billion vs $1.52 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | INVA |
|---|---|---|
| Share price | $17.61 | $21.06 |
| Market cap | $1.88B | $1.52B |
| 1-day change | -0.37% | +0.91% |
| YTD return | — | +4.40% |
| 1-year return | — | +20.15% |
| 5-year return | — | +25.65% |
| P/E ratio (TTM) | — | 4.92 |
| Forward P/E | — | 9.53 |
| EPS (TTM) | $-1.16 | $4.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $411.33M |
| Revenue growth (YoY) | — | +14.67% |
| Net income (latest FY) | — | $271.17M |
| Gross margin | — | 74.80% |
| Operating margin | — | 39.81% |
| Net margin | — | 65.92% |
| 52-week high | $23.21 | $25.15 |
| 52-week low | $16.64 | $16.52 |
| Distance from 52-week high | -24.13% | -16.26% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +66.19% |
| Average volume | 1.25M | 819.03K |
| Shares outstanding | 106.80M | 72.25M |
| Employees | 100 | 159 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Innoviva
INVA stock →Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 159 employees
ADRX vs INVA FAQ
Which is bigger, ADARx Pharmaceuticals or Innoviva?
ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.88B compared with $1.52B for Innoviva (INVA).
Are ADARx Pharmaceuticals and Innoviva in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.